Ignite Creation Date:
2024-05-05 @ 5:24 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00441350
Status:
COMPLETED
Last Update Posted:
2021-07-28
First Post:
2007-02-27
Brief Title:
OlmesartanHCTZ 40125 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential Hypertension
Sponsor:
Menarini Group
Organization:
Menarini Group
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Hypertension |
Keywords: